ClinConnect ClinConnect Logo
Search / Trial NCT06978257

Digital Positive Affect Intervention Study

Launched by NATIONAL UNIVERSITY OF SINGAPORE · May 10, 2025

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Anxiety Depression

ClinConnect Summary

The Digital Positive Affect Intervention Study is looking at a new online program designed to help adults with mild to moderate anxiety and depression. This study compares a digital program that focuses on boosting positive emotions with a self-monitoring app that helps people keep track of their feelings. The hope is that the digital program will not only reduce symptoms of anxiety and depression but also improve overall mental health, sleep quality, and life satisfaction over a six-week period.

To participate, individuals must be between the ages of 21 and 64, speak and write in English, and own a smartphone with a Singapore phone number. They should also have mild symptoms of anxiety or depression, as measured by specific questionnaires. Participants will engage with the online program for six weeks and will be asked to complete surveys about their mental health at various points during and after the study. This trial is currently recruiting, and findings will help determine if this digital approach is effective in enhancing emotional well-being.

Gender

ALL

Eligibility criteria

  • Inclusion criteria
  • Adults aged between 21 and 64 years
  • Proficient in written and spoken English
  • Ability to provide informed consent
  • Scores between 5 and 14 on the Generalized Anxiety Disorder-7 (GAD-7) scale OR
  • Scores between 5 and 19 on the Patient Health Questionnaire-9 (PHQ-9) scale
  • Scores below 6 on the Altman Self-Rating Mania (ASRM) scale
  • Possess an active smartphone with a valid Singapore phone number
  • Mainly based in Singapore, within the next 15 months Exclusion criteria
  • Failure to meet the above inclusion criteria
  • Significant suicidal thoughts within the past two weeks, defined as self-reporting "more than half the days" or "nearly every day" on the PHQ-9 Item 9.
  • Received psychiatric diagnoses of bipolar disorder, disorders of psychosis, severe clinical anxiety, or severe clinical depression.
  • Severe clinical anxiety (scores of 15 to 21 on the GAD-7)
  • Severe clinical depression (scores of 20-27 on the PHQ-9)

About National University Of Singapore

The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported